AU6760294A - Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis - Google Patents

Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis

Info

Publication number
AU6760294A
AU6760294A AU67602/94A AU6760294A AU6760294A AU 6760294 A AU6760294 A AU 6760294A AU 67602/94 A AU67602/94 A AU 67602/94A AU 6760294 A AU6760294 A AU 6760294A AU 6760294 A AU6760294 A AU 6760294A
Authority
AU
Australia
Prior art keywords
antibodies
diagnosis
pharmaceutical compositions
peptides derived
shock syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67602/94A
Inventor
Anthony W Chow
Winnie W. S Kum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU6760294A publication Critical patent/AU6760294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU67602/94A 1993-05-03 1994-05-03 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis Abandoned AU6760294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5851893A 1993-05-03 1993-05-03
US058518 1993-05-03
PCT/IB1994/000140 WO1994025483A1 (en) 1993-05-03 1994-05-03 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis

Publications (1)

Publication Number Publication Date
AU6760294A true AU6760294A (en) 1994-11-21

Family

ID=22017314

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67602/94A Abandoned AU6760294A (en) 1993-05-03 1994-05-03 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis

Country Status (2)

Country Link
AU (1) AU6760294A (en)
WO (1) WO1994025483A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023504A1 (en) * 1995-12-22 1997-07-03 Smithkline Beecham Plc Two-component signal transduction response regulator polypeptides from staphylococcus aureus
EP0885297A4 (en) * 1996-02-20 1999-11-24 Smithkline Beecham Corp Novel era
US6107071A (en) 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
DE10116042A1 (en) * 2001-03-30 2002-10-24 Fresenius Hemocare Gmbh Exotoxin ligand

Also Published As

Publication number Publication date
WO1994025483A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
AU5278096A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
IL110160A0 (en) Phosphopeptides, their preparation and pharmaceutical compositions containing them
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU3827097A (en) Naphthopyrans, compositions and articles containing them
HUP9901874A3 (en) Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU7508494A (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
IL111011A0 (en) Bisbenzimidazole compounds, their preparation and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
GR3033591T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
AU7230194A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
AU8147094A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU2030297A (en) Taxoids, preparation thereof and pharmaceutical compositions containing same
AU6858594A (en) Human influenza virus peptides binding hla-t molecule
AU6760294A (en) Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis
GR3034203T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
AU8146994A (en) Novel taxicine derivatives, their preparation and pharmaceutical compositions containing them
AU2741795A (en) Taxoids, preparation thereof and pharmaceutical compositions containing them
AU6240494A (en) Ribosome inactivating protein compositions having reduced antigenicity